Filing Flows › Biocryst Pharmaceuticals (BCRX) › How it makes money
How Biocryst Pharmaceuticals (BCRX) makes money
Biocryst Pharmaceuticals (BCRX) made $180M of revenue in the third quarter 2026 (Q3 2026), +13% from a year earlier. Product brought in $172M (96%); License and other revenues brought in $8.0M (4%). Of every dollar of revenue, 30¢ was left as operating profit, 21¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Product | $172M | 95.6% | — | +9% |
| License and other revenues | $8.0M | 4.4% | — | +382% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $180M | 100.0% |
| Operating profit | $53.3M | 29.6% |
| Income tax | $669K | 0.4% |
| Net earnings | $37.9M | 21.0% |
| Operating cash flow | $33.0M | 18.3% |
| Free cash flow | $32.8M | 18.2% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $180M | +13% |
| Q2 2026 | $218M | +34% |
| Q1 2026 | $156M | +8% |
| Q4 2025 | $407M | +209% |
| Q3 2025 | $159M | +36% |
| Q2 2025 | $163M | +49% |
| Q1 2025 | $146M | +57% |
From Biocryst Pharmaceuticals' 10-Q filed Nov 4, 2026 (on EDGAR).
Questions
How does Biocryst Pharmaceuticals make money?
Biocryst Pharmaceuticals (BCRX) made $180M of revenue in the third quarter 2026 (Q3 2026), +13% from a year earlier. Product brought in $172M (96%); License and other revenues brought in $8.0M (4%). Of every dollar of revenue, 30¢ was left as operating profit, 21¢ was left as net earnings.
What is Biocryst Pharmaceuticals' biggest business?
Product: $172M in the third quarter 2026, 96% of revenue, +9% from a year earlier.
What is Biocryst Pharmaceuticals' profit margin?
Net earnings were $37.9M, 21.0% of revenue, in the third quarter 2026; the operating margin was 29.6%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.